Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma : Standard 3D Conformational Radiotherapy Versus Intensity-modulated Radiotherapy With Simultaneous-integrated Boost Guided by Magnetic Resonance Spectroscopic Imaging

NCT01507506 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT01507506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01507506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma : Standard 3D Conformational Radiotherapy Versus Intensity-modulated Radiotherapy With Simultaneous-integrated Boost Guided by Magnetic Resonance Spectroscopic Imaging
Lead sponsor
Institut Claudius Regaud
Phase
Phase 3
Overall status
Terminated
Start date
March 15, 2011
Completion date
January 2, 2020
Enrollment
180 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma